Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration
LONDON, UK – 24–25 June 2025
Projected to reach $1,139.4 billion by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution? From complex biologics and increased demand for patient self-administration to advanced delivery technologies, the answers will be centre stage at this year’s Injectable Drug Delivery Conference.
SAE Media Group is delighted to welcome key players from the pharmaceutical and biotech community to London this June for two days of industry-leading insights, cross-sector collaboration, and innovation shaping the future of parenteral therapeutics.
Co-chair Rachel Koppelman, Head of Device Engineering at Sandoz, sets the tone for the event:
“This is the perfect opportunity to benchmark your drug delivery programme and optimise the development of your injectable portfolio.”
🌟 Spotlight Sessions: Meet the 2025 Industry Leaders
The 2025 agenda features expert-led case studies and panel debates on device design, materials science, regulatory strategy, and combination product development. Confirmed spotlight speakers include:
- Rachel Koppelman, Head of Device Engineering, Sandoz
- Joel Richard, Executive Head, Product Development, DBV Technologies
- Conor O’Neill, Head of Packaging Development and Design, GSK
- Chantal Pfaffen, Global Lead Material Qualification, CSL Behring
- Clovis Pichon, Head of Device Program Leadership, UCB Pharma
🔎 See the full list of expert speakers on the Speakers Page
🧭 Who’s Attending: A Glimpse at the Global Network
With under six weeks to go, confirmed attendees include experts from Pfizer, GSK, CSL Behring, Sanofi, Roche, Sandoz, UCB Medical Devices, West Pharmaceutical Services, MedinCell, and more. Delegates span senior leadership, R&D, packaging, device engineering, formulation, and regulatory affairs—ensuring a diverse and high-value networking environment.
📄 View the current attendee list: Current Attendees
🚀 Innovation, Insight, and Interaction
This year’s agenda is built around the most urgent challenges and boldest opportunities in injectable drug delivery, including:
- Subcutaneous delivery of biologics and peptides
- Large-volume and long-acting injectables
- Sustainable device development and material sourcing
- Extractables/Leachables, biocompatibility, and toxicology
📅 Explore the full two-day programme: Agenda Page
🔔 Time Is Running Out – Will You Be Joining Us?
With less than six weeks to go, now is the time to confirm your place at the industry’s premier injectable drug delivery event. Don’t miss this opportunity to engage with leading voices, forge meaningful partnerships, and stay ahead of the innovation curve.
🎟️ Register now: Injectable Drug Delivery 2025
Conference Producer:
Katie Ogden - Portfolio Manager
📧 katie.Ogden@saemediagroup.com | 📞 +44 (0) 207827 6118
Registration Enquiries:
Adam Smith – Business Development Executive
📧 adam.smith@saemediagroup.com | 📞 +44 (0) 20 7827 6183
Sponsorship Opportunities:
Ash Khan – Sponsorship Sales Manager
📧 ash.khan@saemediagroup.com | 📞 +44 (0) 20 7827 6110
Media Contact:
Elliott Karmel – Marketing Lead
📧 elliott.karmel@saemediagroup.com | 📞 +44 (0) 20 8449 1159
